Pharmacovigilance

The working group deals with current topics and questions regarding drug safety in clinical trials and after approval. The working group meets two to three times a year, with an exchange of experiences with the working groups “GCP Quality Assurance/Monitoring” and “GCP Clinical Operations”. The working group meetings take place at different locations, one member takes over the organization and hosts the meeting. Topics are current legal and regulatory requirements (national and international) as well as practical issues. Furthermore, members report on continuous training events. In addition to all this, the discussion and the exchange of experiences are an important part of these working group meetings.